SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-037511
Filing Date
2024-08-15
Accepted
2024-08-15 16:08:47
Documents
15
Period of Report
2024-08-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20034225_8k.htm   iXBRL 8-K 24908
2 EXHIBIT 99.1 ef20034225_ex99-1.htm EX-99.1 26351
6 image00001.jpg GRAPHIC 4171
  Complete submission text file 0001140361-24-037511.txt   197702

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcel-20240815.xsd EX-101.SCH 3856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcel-20240815_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcel-20240815_pre.xml EX-101.PRE 16038
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20034225_8k_htm.xml XML 4044
Mailing Address 64 SIDNEY ST. CAMBRIDGE MA 02139
Business Address 64 SIDNEY ST. CAMBRIDGE MA 02139 7349305555
Vericel Corp (Filer) CIK: 0000887359 (see all company filings)

IRS No.: 943096597 | State of Incorp.: MI | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35280 | Film No.: 241212487
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)